Our colleagues Anthony Argiropoulos and Sheila A. Woolson have a post on the Workforce Bulletin blog that will be of interest to our readers in the health care and life sciences industry: “Coronavirus Emergency Declarations Trigger Anti-Price Gouging Laws.”
Following is an excerpt:
The particulars of the laws vary with each state. Some states set a percentage above which the merchant cannot increase the price. Others simply state the price increase cannot be “unconscionable.” Some laws apply to any party in the distribution chain, whereas others make allowances for ...
Telemedicine has made great recent strides in terms of greater acceptance and deployment. That said, a lot of work still needs to be done. Two recent surveys, one of tech savvy consumers and another of health care stakeholders make that case.
The first survey was done on behalf of a consumer health engagement company. It makes for sobering reading. The survey polled 500 insured consumers who are also users of mobile health applications. Some interesting findings:
- Almost 40% have not heard of telemedicine.
- 42% who have not used telemedicine and prefer an in-person physician visit ...
Recent Updates
- When AI Becomes Part of Medicine: Why CMS’s AI Questions Matter Now
- Watch: Gender-Affirming Care: What Health Care Providers Need to Know About Federal Enforcement – Thought Leaders in Health Law
- Executive Order 14321 at One Year: Civil Commitment Policy Shifts and Provider Impact
- Watch: FDA’s 2026 Enforcement Priorities: What In-House Counsel Must Know – Thought Leaders in Health Law
- The Future of 340B: New Bills Offer Competing Solutions to Modernize the 340B Drug Discount Program